People International Society Honors Two Researchers For Breakthrough Work In Cancer Diagnostics; Roche Institute Recognizes Scientist for Protein Transport Studies

David M. Goldenberg, president of the Garden State Cancer Center, a cancer research institution in Newark, N.J., and Jean-Pierre Mach, a professor of biochemistry in the faculty of medicine at Lausanne University, Switzerland--were honored last month with the 1994 Abbott Award. The award was presented at the 22nd meeting of the International Society for Oncodevelopmental Biology (ISOBM), held in Groningen, the Netherlands. ISOBM, cu

Written byNeeraja Sankaran
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ISOBM, currently headquartered in Freiberg, Germany, is an international scholarly society for immunologists and cancer biologists who have an interest in tumor markers. It produces a monthly research journal, Tumor Biology, published by S. Kargers Publishers Inc. of Basel, Switzerland. The annual Abbott Award was established by Abbott Park, Ill.-based Abbott Laboratories five years ago to recognize ISOBM members for their research and service to the society.

Goldenberg and Mach worked independently but along parallel lines to develop a technique for detecting cancers using radioactive antibodies specific for certain molecules--called markers--present on the surface of tumor cells. Goldenberg published the clinical paper that demonstrated the use of the technique (D.M. Goldenberg et al., New England Journal of Medicine, 298:1384-8, 1978), and Mach's group followed closely with a critical evaluation of the technique, demonstrating the specificity of localization of the antibodies (J.P. Mach et al., NEJM, 303:5-10, 1980).

"When we started ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies